Clinical Trial Update: Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update from Eli Lilly evaluated long-term effects of insulin plus metformin on overall and postprandial glycemic control in Type 2 diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• metformin (metformin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED